骨质疏松症与干眼关系的研究进展
Research Progress on the Relationship between Osteoporosis and Dry Eye
DOI: 10.12677/ACM.2024.141111, PDF,   
作者: 张 宸:西安医学院研究生院,陕西 西安;空军军医大学唐都医院眼科,陕西 西安;马 楠*:空军军医大学唐都医院眼科,陕西 西安
关键词: 干眼症骨质疏松性激素维生素D炎症Dry Eye Disease Osteoporosis Sex Hormones Vitamin D Inflammation
摘要: 干眼病是由于泪腺泪液分泌减少,泪水蒸发增加或泪液质量差引起,会导致眼表炎症、损伤及神经感觉异常。骨质疏松是一种与炎症和激素失衡相关的多因素疾病,特点是骨量减少、骨微结构破坏和骨脆性增加,这些都会增加骨折的风险。干眼病和骨质疏松有共同的危险因素和流行病学特征,炎症和性激素缺乏已被证明是这两种疾病的基础。有研究报道,骨质疏松通过调节性激素水平、嘌呤能信号传导以及维生素D的水平等方面来影响干眼的发生发展。然而,很少提到这两种疾病的相关性。本文通过对骨质疏松症与干眼病之间的潜在关系进行系统性回顾,介绍骨质疏松与干眼的流行病学、危险因素、发病机制以及近年来主要的治疗手段,为临床医生提供参考。
Abstract: Dry eye disease is caused by reduced tear secretion from the lacrimal gland, increased tear evapo-ration or poor tear quality, which can lead to ocular surface inflammation, damage and abnormal nerve sensation. Osteoporosis is a multifactorial disease associated with inflammation and hormo-nal imbalance, characterized by reduced bone mass, destruction of bone microarchitecture, and in-creased bone fragility, which increase the risk of fractures. Dry eye disease and osteoporosis share common risk factors and epidemiological features, and inflammation and sex hormone deficiencies have been shown to underlie both diseases. Studies have reported that osteoporosis affects the oc-currence and development of dry eye by regulating sex hormone levels, purinergic signaling, and vitamin D levels. However, the correlation between these two diseases is rarely mentioned. This ar-ticle conducts a systematic review of the potential relationship between osteoporosis and dry eye disease, introduces the epidemiology, risk factors, pathogenesis, and main treatments in recent years of osteoporosis and dry eye disease, and provides a reference for clinicians.
文章引用:张宸, 马楠. 骨质疏松症与干眼关系的研究进展[J]. 临床医学进展, 2024, 14(1): 795-803. https://doi.org/10.12677/ACM.2024.141111

参考文献

[1] Craig, J.P., Nichols, K.K., Akpek, E.K., Caffery, B., Dua, H.S., Joo, C.K., et al. (2017) TFOS DEWS II Definition and Classification Report. The Ocular Surface, 15, 276-283. [Google Scholar] [CrossRef] [PubMed]
[2] Tsubota, K., Pflugfelder, S.C., Liu, Z., Baudouin, C., Kim, H.M., Messmer, E.M., et al. (2020) Defining Dry Eye from a Clinical Perspective. International Journal of Molecular Sciences, 21, Article No. 9271. [Google Scholar] [CrossRef] [PubMed]
[3] Johnston, C.B. and Dagar, M. (2020) Osteoporosis in Older Adults. The Medical Clinics of North America, 104, 873-884. [Google Scholar] [CrossRef] [PubMed]
[4] Jeng, Y.T., Lin, S.Y., Hu, H.Y., Lee, O.K. and Kuo, L.L. (2018) Osteoporosis and Dry Eye Syndrome: A Previously Unappreciated Association That May Alert Active Prevention of Fall. PLOS ONE, 13, e0207008. [Google Scholar] [CrossRef] [PubMed]
[5] Papas, E.B. (2021) The Global Prevalence of Dry Eye Disease: A Bayesian View. Ophthalmic & Physiological Optics: The Journal of the British College of Ophthalmic Opticians (Optometrists), 41, 1254-1266. [Google Scholar] [CrossRef] [PubMed]
[6] Sözen, T., Özışık, L. and Başaran, N. (2017) An Overview and Manage-ment of Osteoporosis. European Journal of Rheumatology, 4, 46-56. [Google Scholar] [CrossRef] [PubMed]
[7] Villani, E., Canton, V., Magnani, F., Viola, F., Nucci, P. and Ratiglia, R. (2013) The Aging Meibomian Gland: An in Vivo Confocal Study. Investigative Ophthalmology & Visual Science, 54, 4735-4740. [Google Scholar] [CrossRef] [PubMed]
[8] Muñoz, M., Robinson, K. and Shibli-Rahhal, A. (2020) Bone Health and Osteoporosis Prevention and Treatment. Clinical Obstetrics and Gynecology, 63, 770-787. [Google Scholar] [CrossRef
[9] Golebiowski, B., Badarudin, N., Eden, J., You, J., Hampel, U. and Stapleton, F. (2017) Does Endogenous Serum Oestrogen Play a Role in Meibomian Gland Dysfunction in Post-menopausal Women with Dry Eye? The British Journal of Ophthalmology, 101, 218-222. [Google Scholar] [CrossRef] [PubMed]
[10] Cheng, C.H., Chen, L.R. and Chen, K.H. (2022) Osteo-porosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. International Journal of Molecular Sciences, 23, Article No. 1376. [Google Scholar] [CrossRef] [PubMed]
[11] Putney, J.W. and Bird, G.S. (2014) Calcium Signaling in Lacrimal Glands. Cell Calcium, 55, 290-296. [Google Scholar] [CrossRef] [PubMed]
[12] Tsubota, K., Monden, Y., Yagi, Y., Goto, E. and Shimmura, S. (1999) New Treatment of Dry Eye: The Effect of Calcium Ointment through Eyelid Skin Delivery. The British Journal of Ophthalmology, 83, 767-770. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, J., Dong, Y. and Wang, Y. (2020) Vitamin D Deficiency Is Associ-ated with Dry Eye Syndrome: A Systematic Review and Meta-Analysis. Acta Ophthalmologica, 98, 749-754. [Google Scholar] [CrossRef] [PubMed]
[14] Lane, N.E. (2006) Epidemiology, Etiology, and Diagnosis of Osteoporosis. American Journal of Obstetrics and Gynecology, 194, S3-S11. [Google Scholar] [CrossRef] [PubMed]
[15] Esmaeli, B., Harvey, J.T. and Hewlett, B. (2000) Immunohisto-chemical Evidence for Estrogen Receptors in Meibomian Glands. Ophthalmology, 107, 180-184. [Google Scholar] [CrossRef
[16] Nuzzi, R. and Caselgrandi, P. (2022) Sex Hormones and Their Effects on Ocular Disorders and Pathophysiology: Current Aspects and Our Experience. International Journal of Molecular Sciences, 23, Article No. 3269. [Google Scholar] [CrossRef] [PubMed]
[17] Narita, S., Goldblum, R.M., Watson, C.S., Brooks, E.G., Estes, D.M., Curran, E.M. and Midoro-Horiuti, T. (2007) Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-Mediated Release of Allergic Mediators. Environmental Health Perspectives, 115, 48-52. [Google Scholar] [CrossRef] [PubMed]
[18] Beauregard, C. and Brandt, P. (2004) Down Regulation of Interleu-kin-1beta-Induced Nitric Oxide Production in Lacrimal Gland Acinar Cells by Sex Steroids. Current Eye Research, 29, 59-66. [Google Scholar] [CrossRef] [PubMed]
[19] Grasso, A., Di Zazzo, A., Giannaccare, G., Sung, J., Inomata, T., Shih, K.C., et al. (2021) Sex Hormones Related Ocular Dryness in Breast Cancer Women. Journal of Clinical Medicine, 10, Article No. 2620. [Google Scholar] [CrossRef] [PubMed]
[20] Khosla, S. and Monroe, D.G. (2018) Regulation of Bone Metabolism by Sex Steroids. Cold Spring Harbor Perspectives in Medicine, 8, a031211. [Google Scholar] [CrossRef] [PubMed]
[21] Gosset, A., Pouillès, J.M. and Trémollieres, F. (2021) Meno-pausal Hormone Therapy for the Management of Osteoporosis. Best Practice & Research Clinical Endocrinology & Me-tabolism, 35, Article ID: 101551. [Google Scholar] [CrossRef] [PubMed]
[22] Clarke, B.L. and Khosla, S. (2009) Androgens and Bone. Ster-oids, 74, 296-305. [Google Scholar] [CrossRef] [PubMed]
[23] Adler, R.A. (2014) Osteoporosis in Men: A Review. Bone Re-search, 2, Article No. 14001. [Google Scholar] [CrossRef] [PubMed]
[24] Terakado, K., Yogo, T., Kohara, Y., Soeta, S., Nezu, Y., Harada, Y., et al. (2014) Conjunctival Expression of the P2Y2 Receptor and the Effects of 3% Diquafosol Ophthalmic Solution in Dogs. Veterinary Journal (London, England: 1997), 202, 48-52. [Google Scholar] [CrossRef] [PubMed]
[25] Lau, O.C., Samarawickrama, C. and Skalicky, S.E. (2014) P2Y2 Receptor Agonists for the Treatment of Dry Eye Disease: A Re-view. Clinical Ophthalmology (Auckland, N.Z.), 8, 327-334. [Google Scholar] [CrossRef
[26] Abbracchio, M.P., Burnstock, G., Boeynaems, J.M., Barnard, E.A., Boyer, J.L., Kennedy, C., et al. (2006) International Union of Pharmacology LVIII: Update on the P2Y G Pro-tein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy. Pharmacological Reviews, 58, 281-341. [Google Scholar] [CrossRef] [PubMed]
[27] Lips, P. and van Schoor, N.M. (2011) The Effect of Vitamin D on Bone and Osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 585-591. [Google Scholar] [CrossRef] [PubMed]
[28] Yildirim, P., Garip, Y., Karci, A.A. and Guler, T. (2016) Dry Eye in Vitamin D Deficiency: More than an Incidental Association. International Journal of Rheumatic Diseases, 19, 49-54. [Google Scholar] [CrossRef
[29] Demirci, G., Karaman Erdur, S., Ozsutcu, M., Eliacik, M., Olmus-celik, O., Aydin, R. and Kocabora, M.S. (2018) Dry Eye Assessment in Patients with Vitamin D Deficiency. Eye & Contact Lens, 44, S62-S65. [Google Scholar] [CrossRef
[30] Meng, Y.F., Xin, Q., Lu, J., Xiao, P. and Li, J. (2019) Asso-ciation between Single Nucleotide Polymorphisms in the Vitamin D Receptor and Incidence of Dry Eye Disease in Chi-nese Han Population. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25, 4759-4765. [Google Scholar] [CrossRef
[31] Yao, P., Sun, L., Lu, L., Ding, H., Chen, X., Tang, L., et al. (2017) Effects of Genetic and Nongenetic Factors on Total and Bioavailable 25(OH)D Responses to Vitamin D Sup-plementation. The Journal of Clinical Endocrinology and Metabolism, 102, 100-110. [Google Scholar] [CrossRef] [PubMed]
[32] Azizieh, F., Alyahya, K.O. and Raghupathy, R. (2016) Association be-tween Levels of Vitamin D and Inflammatory Markers in Healthy Women. Journal of Inflammation Research, 9, 51-57. [Google Scholar] [CrossRef
[33] Guzmán, M., Keitelman, I., Sabbione, F., Trevani, A.S., Giordano, M.N. and Galletti, J.G. (2016) Desiccating Stress-Induced Disruption of Ocular Surface Immune Tolerance Drives Dry Eye Disease. Clinical and Experimental Immunology, 184, 248-256. [Google Scholar] [CrossRef] [PubMed]
[34] Chi, W., Hua, X., Chen, X., Bian, F., Yuan, X., Zhang, L., et al. (2017) Mitochondrial DNA Oxidation Induces Imbalanced Ac-tivity of NLRP3/NLRP6 Inflammasomes by Activation of Caspase-8 and BRCC36 in Dry Eye. Journal of Autoimmunity, 80, 65-76. [Google Scholar] [CrossRef] [PubMed]
[35] Perez, V.L., Stern, M.E. and Pflugfelder, S.C. (2020) In-flammatory Basis for Dry Eye Disease Flares. Experimental Eye Research, 201, Article ID: 108294. [Google Scholar] [CrossRef] [PubMed]
[36] Fischer, V. and Haffner-Luntzer, M. (2022) Interaction between Bone and Immune Cells: Implications for Postmenopausal Osteoporosis. Seminars in Cell & Developmental Biology, 123, 14-21. [Google Scholar] [CrossRef] [PubMed]
[37] Clowes, J.A., Riggs, B.L. and Khosla, S. (2005) The Role of the Immune System in the Pathophysiology of Osteoporosis. Immunological Reviews, 208, 207-227. [Google Scholar] [CrossRef] [PubMed]
[38] Barbour, K.E., Boudreau, R., Danielson, M.E., Youk, A.O., Wactawski-Wende, J., Greep, N.C., et al. (2012) Inflammatory Markers and the Risk of Hip Fracture: The Women’s Health Initiative. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 27, 1167-1176. [Google Scholar] [CrossRef] [PubMed]
[39] Cauley, J.A., Danielson, M.E., Boudreau, R.M., Forrest, K.Y., Zmuda, J.M., Pahor, M., et al. (2007) Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study. Journal of Bone and Mineral Research: The Official Journal of the American Soci-ety for Bone and Mineral Research, 22, 1088-1095. [Google Scholar] [CrossRef] [PubMed]
[40] Scuderi, G., Con-testabile, M.T., Gagliano, C., Iacovello, D., Scuderi, L. and Avitabile, T. (2012) Effects of Phytoestrogen Supplementa-tion in Postmenopausal Women with Dry Eye Syndrome: A Randomized Clinical Trial. Canadian Journal of Ophthal-mology, 47, 489-492. [Google Scholar] [CrossRef] [PubMed]
[41] Jin, X., Lin, Z., Liu, Y., Lin, L. and Zhu, B. (2016) Hormone Replacement Therapy Benefits Meibomian Gland Dysfunction in Perimenopausal Women. Medicine, 95, e4268. [Google Scholar] [CrossRef
[42] Dang, A., Nayeni, M., Mather, R. and Mal-vankar-Mehta, M.S. (2020) Hormone Replacement Therapy for Dry Eye Disease Patients: Systematic Review and Me-ta-Analysis. Canadian Journal of Ophthalmology, 55, 3-11. [Google Scholar] [CrossRef] [PubMed]
[43] Nanavaty, M.A., Long, M. and Malhotra, R. (2014) Transdermal Androgen Patches in Evaporative Dry Eye Syndrome with Androgen Deficiency: A Pilot Study. The British Journal of Ophthalmology, 98, 567-569. [Google Scholar] [CrossRef] [PubMed]
[44] Albright, F. (1947) Osteoporosis. Annals of Internal Med-icine, 27, 861-882. [Google Scholar] [CrossRef] [PubMed]
[45] (2017) The 2017 Hormone Therapy Position Statement of the North American Menopause Society. Menopause (New York, N.Y.), 24, 728-753. [Google Scholar] [CrossRef
[46] Bassuk, S.S. and Manson, J.E. (2016) The Timing Hy-pothesis: Do Coronary Risks of Menopausal Hormone Therapy Vary by Age or Time Since Menopause Onset? Metabo-lism: Clinical and Experimental, 65, 794-803. [Google Scholar] [CrossRef] [PubMed]
[47] Watts, P., Sahai, A., Kumar, P.R., Shamshad, M.A., Trivedi, G.K. and Tyagi, L. (2020) A Prospective Study to Assess the Role of Vitamin D Individually and in Combination with Cyclosporine in the Treatment of Dry Eye in Patients with Deficient Serum 25(OH)D Levels. Indian Journal of Oph-thalmology, 68, 1020-1026. [Google Scholar] [CrossRef
[48] Hwang, J.S., Lee, Y.P. and Shin, Y.J. (2019) Vitamin D Enhances the Efficacy of Topical Artificial Tears in Patients with Dry Eye Disease. Cornea, 38, 304-310. [Google Scholar] [CrossRef
[49] Bischoff-Ferrari, H.A., Dawson-Hughes, B., Orav, E.J., Staehelin, H.B., Meyer, O.W., Theiler, R., et al. (2016) Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Internal Medicine, 176, 175-183. [Google Scholar] [CrossRef] [PubMed]
[50] Gregson, C.L., Armstrong, D.J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N.J.L., et al. (2022) UK Clinical Guideline for the Prevention and Treatment of Osteoporosis. Ar-chives of Osteoporosis, 17, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
[51] Yao, P., Bennett, D., Mafham, M., Lin, X., Chen, Z., Armitage, J. and Clarke, R. (2019) Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-Analysis. JAMA Network Open, 2, e1917789. [Google Scholar] [CrossRef] [PubMed]
[52] Heidari, M., Noorizadeh, F., Wu, K., Inomata, T. and Mashaghi, A. (2019) Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy. Journal of Clinical Medicine, 8, Article No. 1439. [Google Scholar] [CrossRef] [PubMed]
[53] Sano, K., Kawashima, M., Ito, A., Inaba, T., Morimoto, K., Watanabe, M. and Tsubota, K. (2014) Aerobic Exercise Increases Tear Secretion in Type 2 Diabetic Mice. Investigative Ophthalmology & Visual Science, 55, 4287-4294. [Google Scholar] [CrossRef] [PubMed]
[54] Yuan, Y., Chen, X., Zhang, L., Wu, J., Guo, J., Zou, D., et al. (2016) The Roles of Exercise in Bone Remodeling and in Prevention and Treatment of Osteoporosis. Progress in Biophysics and Molecular Biology, 122, 122-130. [Google Scholar] [CrossRef] [PubMed]
[55] Zhang, L., Zheng, Y.L., Wang, R., Wang, X.Q. and Zhang, H. (2022) Exercise for Osteoporosis: A Literature Review of Pathology and Mechanism. Frontiers in Immunology, 13, Article ID: 1005665. [Google Scholar] [CrossRef] [PubMed]
[56] Stewart, L.K., Flynn, M.G., Campbell, W.W., Craig, B.A., Robinson, J.P., McFarlin, B.K., et al. (2005) Influence of Exercise Training and Age on CD14+ Cell-Surface Expression of Toll-Like Receptor 2 and 4. Brain, Behavior, and Immunity, 19, 389-397. [Google Scholar] [CrossRef] [PubMed]